Skip to content

EyePoint, Inc. EYPT Other Commercial Liabilities

Other Commercial Liabilities at other companies

Ocular Therapeutix logo
Ocular TherapeutixOCUL
Kodiak Sciences Inc logo
Kodiak Sciences IncKOD
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT

Other financials

Income statement

See full
Revenue$696.0K-97.2%
Gross profit$9.8M-30.1%
Operating income-$87.2M-78.6%
Net income-$84.8M-87.7%
EPS (diluted)-$0.99-52.3%

Balance sheet

See full
Cash & equivalents$77.7M-8.7%
Total debt$22.3M-7.3%
Total equity$230.5M-22.8%
Total assets$288.2M-20.5%

Cash flow

See full
Operating cash flow-$80.5M-51.6%
CapEx$997.0K+261%
Free cash flow-$81.5M-52.7%

Valuation

See full
Market cap$1.21B+108%
Enterprise value$1.15B+122%
P/S158.5×+148×

Profitability

See full
Operating margin-3,700.9%-4,042pp
Net margin-3,566.6%-3,874pp
FCF margin-3,565.9%-3,884pp

Returns & leverage

See full
Return on equity-102.7%+1,157pp
Debt / equity0.1×0.0×
Current ratio6.7×-1.2×

Where this comes from

Reported directly by EyePoint, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: EyePoint, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about EyePoint, Inc. 's other commercial liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is EyePoint, Inc. 's other commercial liabilities?
EyePoint, Inc. (EYPT) reported other commercial liabilities of $16.44M in Q1 2026.
How has EyePoint, Inc. 's other commercial liabilities changed year-over-year?
EyePoint, Inc. 's other commercial liabilities decreased by 9.6% year-over-year, from $18.18M to $16.44M.
What is the long-term trend for EyePoint, Inc. 's other commercial liabilities?
Over 5 years (2020 to 2025), EyePoint, Inc. 's other commercial liabilities has grown at a 23.6% compound annual growth rate (CAGR), from $8.45M to $24.39M.